Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
3
×
boston top stories
clinical trials
life sciences
national blog main
allergan
boston
eli lilly
fda
genentech
national top stories
san francisco blog main
san francisco top stories
10x genomics
abbvie
amgen
anemia
antibiotic
astrazeneca
autism
autism spectrum disorder
avapritinib
avexis
biogen
blueprint medicines
boulder/denver blog main
boulder/denver top stories
brian kaspar
bristol-myers squibb
cadent therapeutics
celgene
centers for disease control and prevention
chinook therapeutics
clostridium difficile
community-acquired bacterial pneumonia
crispr
cstone pharmaceuticals
cynthia collins
dana hilt
What
regulatory
3
×
fda
allergan
approval
august
bio
biotech
blessing
blueprint
bosley
busy
cancer
candidate
ceo
check
clinical
crispr
currently
cusp
days
decisions
depart
devices
drug
drugs
editas
editing
experimental
gene
humans
katrine
legacy
marketing
medicine
medicines
million
muscle
news
nods
opioid
Language
unset
Current search:
regulatory
×
biotech
×
" boston blog main "
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial